Back
Entrada Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
51
TRDA
Entrada Therapeutics, Inc.
Last Price:
$10.62
Seasonality Move:
-39.89%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TRDA is experiencing slight selling pressure.
Entrada Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 11.01 | Sell |
| 20-day SMA: | 10.55 | Buy |
| 50-day SMA: | 8.57 | Buy |
| 200-day SMA: | 7.58 | Buy |
| 8-day EMA: | 6.9 | Buy |
| 20-day EMA: | 3.6 | Buy |
| 50-day EMA: | 1.62 | Buy |
| 200-day EMA: | 0.43 | Buy |
Entrada Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.42 | Buy |
| Relative Strength Index (14 RSI): | 59.67 | Buy |
| Chaikin Money Flow: | -70830 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (9.47 - 11.03) | Buy |
| Bollinger Bands (100): | (5.04 - 9.08) | Buy |
Entrada Therapeutics, Inc. Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Entrada Therapeutics, Inc. Stock
Is Entrada Therapeutics, Inc. Stock a Buy?
-
Entrada Therapeutics, Inc. share price is 10.62 while TRDA 8-day simple moving average is 11.01, which is a Sell signal.
-
The stock price of TRDA is 10.62 while Entrada Therapeutics, Inc. 20-day SMA is 10.55, which makes it a Buy.
-
Entrada Therapeutics, Inc. 50-day simple moving average is 8.57 while TRDA share price is 10.62, making it a Buy technically.
-
TRDA stock price is 10.62 and Entrada Therapeutics, Inc. 200-day simple moving average is 7.58, creating a Buy signal.
TRDA Technical Analysis vs Fundamental Analysis
Buy
51
Entrada Therapeutics, Inc. (TRDA)
is a Buy
Is Entrada Therapeutics, Inc. a Buy or a Sell?
-
Entrada Therapeutics, Inc. stock is rated a BuyThe current Entrada Therapeutics, Inc. [TRDA] share price is $10.62. The Score for TRDA is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
Entrada Therapeutics, Inc. Stock Info
Market Cap:
405.9M
Price in USD:
10.62
Share Volume:
239.7K
Entrada Therapeutics, Inc. 52-Week Range
52-Week High:
18.76
52-Week Low:
4.93
Buy
51
Entrada Therapeutics, Inc. (TRDA)
is a Buy
Entrada Therapeutics, Inc. Share Price Forecast
-
What is the Entrada Therapeutics, Inc. stock price today?The Entrada Therapeutics, Inc. stock price is 10.62 USD today.
-
Will TRDA stock go up or go down?Entrada Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Entrada Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Entrada Therapeutics, Inc. is not overvalued.
Is Entrada Therapeutics, Inc. Stock a Buy?
-
Entrada Therapeutics, Inc. share price is 10.62 while TRDA 8-day exponential moving average is 6.90, which is a Buy signal.
-
The stock price of TRDA is 10.62 while Entrada Therapeutics, Inc. 20-day EMA is 3.60, which makes it a Buy.
-
Entrada Therapeutics, Inc. 50-day exponential moving average is 1.62 while TRDA share price is 10.62, making it a Buy technically.
-
TRDA stock price is 10.62 and Entrada Therapeutics, Inc. 200-day simple moving average is 0.43, creating a Buy signal.
Fundamental Analysis of Entrada Therapeutics, Inc.
Is Entrada Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, a decrease this year of $4.44 per share, and a decrease next year of $0.64 per share.
Technical Analysis of Entrada Therapeutics, Inc.
Should I short Entrada Therapeutics, Inc. stock?
-
TRDA Moving Average Covergence Divergence (MACD) indicator is 2.42, suggesting Entrada Therapeutics, Inc. is a Buy
-
Entrada Therapeutics, Inc. Relative Strength Index (RSI) is 59.67, which suggest Entrada Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Entrada Therapeutics, Inc. is (9.47 - 11.03), which suggest Entrada Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Entrada Therapeutics, Inc. is (5.04 - 9.08), which suggest Entrada Therapeutics, Inc. is a Buy
* Entrada Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.